124 related articles for article (PubMed ID: 36184649)
1. Cross-sectional evaluation of FGD-avid polyostotic fibrous dysplasia: MRI, CT and PET/MRI findings.
Pozzessere C; Cicone F; Barberio P; Papa A; Coppolino G; Biagini R; Cascini GL
Eur J Hybrid Imaging; 2022 Oct; 6(1):19. PubMed ID: 36184649
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. PET-positive polyostotic fibrous dysplasia mimicking Ollier disease.
Nishio J; Kuwabara Y; Nabeshima S; Iwasaki H; Naito M
In Vivo; 2013; 27(6):821-6. PubMed ID: 24292588
[TBL] [Abstract][Full Text] [Related]
4. Image Findings of Polyostotic Fibrous Dysplasia Mimicking Metastasis in F-18 FDG Positron Emission Tomography/Computed Tomography.
Kamaleshwaran KK; Joseph J; Kalarikal R; Shinto AS
Indian J Nucl Med; 2017; 32(2):137-139. PubMed ID: 28533645
[TBL] [Abstract][Full Text] [Related]
5. 18 F-FDG avid lesion due to coexistent fibrous dysplasia in a child of embryonal rhabdomyosarcoma: source of false positive FDG-PET.
Basu S; Baghel NS; Puri A; Shet T; Merchant NH
J Cancer Res Ther; 2010; 6(1):92-4. PubMed ID: 20479556
[TBL] [Abstract][Full Text] [Related]
6. Unexpected finding of elevated glucose uptake in fibrous dysplasia mimicking malignancy: contradicting metabolism and morphology in combined PET/CT.
Stegger L; Juergens KU; Kliesch S; Wormanns D; Weckesser M
Eur Radiol; 2007 Jul; 17(7):1784-6. PubMed ID: 17066288
[TBL] [Abstract][Full Text] [Related]
7. F-18 FDG PET-positive fibrous dysplasia in a patient with intestinal non-Hodgkin's lymphoma.
Kim M; Kim HS; Kim JH; Jang JH; Chung KJ; Shin MK; Hwang HS; Kim BC; Jung SY
Cancer Res Treat; 2009 Sep; 41(3):171-4. PubMed ID: 19809567
[TBL] [Abstract][Full Text] [Related]
8. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
9. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography/computed tomography imaging appearance of benign and classic "do not touch" osseous lesions.
Elangovan SM; Sebro R
World J Radiol; 2019 Jun; 11(6):81-93. PubMed ID: 31396371
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous whole body (18)F-fluorodeoxyglucose positron emission tomography magnetic resonance imaging for evaluation of pediatric cancer: Preliminary experience and comparison with (18)F-fluorodeoxyglucose positron emission tomography computed tomography.
Pugmire BS; Guimaraes AR; Lim R; Friedmann AM; Huang M; Ebb D; Weinstein H; Catalano OA; Mahmood U; Catana C; Gee MS
World J Radiol; 2016 Mar; 8(3):322-30. PubMed ID: 27028112
[TBL] [Abstract][Full Text] [Related]
13. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
14. Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant?
Kumar R; Hawkins RA; Yeh BM; Wang ZJ
Nucl Med Commun; 2011 Sep; 32(9):802-7. PubMed ID: 21685821
[TBL] [Abstract][Full Text] [Related]
15. Extensive polyostotic fibrous dysplasia evaluated for malignant transformation with
Makis W; Probst S
BJR Case Rep; 2016; 2(3):20150440. PubMed ID: 30459987
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma.
Ponisio MR; McConathy J; Laforest R; Khanna G
Pediatr Radiol; 2016 Aug; 46(9):1258-68. PubMed ID: 27003132
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET/CT of Secondary Epithelioid Angiosarcoma of the Proximal Femur in a Patient With Polyostotic Fibrous Dysplasia.
Hakozaki M; Yamada H; Hasegawa O; Watanabe K; Konno S
Clin Nucl Med; 2017 Oct; 42(10):e454-e456. PubMed ID: 28806239
[TBL] [Abstract][Full Text] [Related]
18. The impact of
Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A
Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508
[TBL] [Abstract][Full Text] [Related]
19. PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokinetics.
Sachpekidis C; Goldschmidt H; Hose D; Pan L; Cheng C; Kopka K; Haberkorn U; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1343-53. PubMed ID: 24562650
[TBL] [Abstract][Full Text] [Related]
20. (18)F-FDG PET/CT for Diagnosis of Osteosclerotic and Osteolytic Vertebral Metastatic Lesions: Comparison with Bone Scintigraphy.
Uchida K; Nakajima H; Miyazaki T; Tsuchida T; Hirai T; Sugita D; Watanabe S; Takeura N; Yoshida A; Okazawa H; Baba H
Asian Spine J; 2013 Jun; 7(2):96-103. PubMed ID: 23741546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
